Dr. David Donath, MD
Claim this profileCentre Hospitalier de l'Université de Montréal (CHUM)
Studies Pancreatic Adenocarcinoma
Studies Stomach Cancer
2 reported clinical trials
3 drugs studied
Area of expertise
1Pancreatic Adenocarcinoma
Stage IV
Stage III
Stage II
2Stomach Cancer
Stage IV
Stage III
Stage II
Clinical Trials David Donath, MD is currently running
Vertebroplasty + SBRT
for Spinal Cancer Pain Management
The goal of treating metastases is to preserve stability and neurological function while reducing pain. The actual standard of care is stereotaxic body radiation therapy (SBRT) alone in non-surgical patients. The added value of vertebroplasty to SBRT is not well documented in the literature, nor whether performing vertebroplasty before radiotherapy treatment leads to a reduction in the rate of fractures and post-SBRT pain.
Recruiting1 award N/A
Alpha Radiation Device
for Advanced Pancreatic Cancer
This trial is testing a new treatment for advanced pancreatic cancer using tiny devices that emit special radiation directly into the tumor. The goal is to see if this method is safe and effective. The radiation aims to kill cancer cells by damaging their DNA, preventing them from growing and spreading.
Recruiting1 award N/A9 criteria
More about David Donath, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David Donath, MD has experience with
- Diffusing Alpha Radiation Emitters Therapy (DaRT)
- Stereotactic Body Radiation Therapy
- Vertebroplasty
Breakdown of trials David Donath, MD has run
Pancreatic Adenocarcinoma
Stomach Cancer
Pancreatic Cancer
Spinal Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Donath, MD specialize in?
David Donath, MD focuses on Pancreatic Adenocarcinoma and Stomach Cancer. In particular, much of their work with Pancreatic Adenocarcinoma has involved Stage IV patients, or patients who are Stage III.
Is David Donath, MD currently recruiting for clinical trials?
Yes, David Donath, MD is currently recruiting for 2 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that David Donath, MD has studied deeply?
Yes, David Donath, MD has studied treatments such as Diffusing Alpha Radiation Emitters Therapy (DaRT), Stereotactic Body Radiation Therapy, Vertebroplasty.
What is the best way to schedule an appointment with David Donath, MD?
Apply for one of the trials that David Donath, MD is conducting.
What is the office address of David Donath, MD?
The office of David Donath, MD is located at: Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec Canada. This is the address for their practice at the Centre Hospitalier de l'Université de Montréal (CHUM).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.